• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列齐特固体复合物与其纳米球之间的溶解度和溶解速率比较。

Comparison of the solubility and dissolution rate between gliclazide solid complex and its nanospheres.

作者信息

Lo Yung-Kuang, Chen Chiu-Ju, Tsai Tong-Rong, Cham Thau-Ming

机构信息

Graduate Institute of Pharmaceutical Sciences, Kaohsiung Medical University, San Min District, Kaohsiung City, Taiwan, ROC.

出版信息

Drug Dev Ind Pharm. 2007 Mar;33(3):301-9. doi: 10.1080/03639040600920622.

DOI:10.1080/03639040600920622
PMID:17454063
Abstract

The solid complex of gliclazide and beta-cyclodextrin was prepared by neutralization method and the precipitation solvent evaporation method was used to prepare gliclazide nanospheres. Fourier-transform infrared spectroscopy and differential scanning calorimetry were used to examine whether gliclazide solid complex and gliclazide nanospheres were successfully formed in this study. The dissolution rate of gliclazide from its nanospheres was faster than its solid complex and pure drug. The morphology of particles for nanospheres showed no crystal character of gliclazide. In summary, the results indicate that nanotechnology provides better effects in solubility and dissolution rate of gliclazide than neutralization method.

摘要

采用中和法制备了格列齐特与β-环糊精的固体复合物,并用沉淀溶剂蒸发法制备了格列齐特纳米球。本研究采用傅里叶变换红外光谱和差示扫描量热法检测格列齐特固体复合物和纳米球是否成功形成。格列齐特从其纳米球中的溶出速率比其固体复合物和纯药物更快。纳米球颗粒的形态显示不出格列齐特的晶体特征。总之,结果表明纳米技术在格列齐特的溶解度和溶出速率方面比中和法具有更好的效果。

相似文献

1
Comparison of the solubility and dissolution rate between gliclazide solid complex and its nanospheres.格列齐特固体复合物与其纳米球之间的溶解度和溶解速率比较。
Drug Dev Ind Pharm. 2007 Mar;33(3):301-9. doi: 10.1080/03639040600920622.
2
Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin.通过与β-环糊精络合提高格列齐特的水溶性和体外溶出速率。
Pharm Acta Helv. 2000 Apr;74(4):365-70. doi: 10.1016/s0031-6865(99)00063-1.
3
Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.格列齐特-聚乙二醇4000固体分散体的制备与表征
Acta Pharm. 2009 Mar;59(1):57-65. doi: 10.2478/v10007-009-0001-3.
4
Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.使用 pH 值变化法并加入十二种具有不同物理化学性质的稳定剂来提高格列齐特的溶解度。
J Pharm Pharm Sci. 2009;12(3):250-65. doi: 10.18433/j31p4p.
5
Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.使用聚乙二醇6000固体分散体提高格列齐特的溶出速率。
AAPS PharmSciTech. 2008;9(2):563-70. doi: 10.1208/s12249-008-9079-z. Epub 2008 May 6.
6
In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.格列齐特:聚乙二醇6000固体分散体系统的体内和体外评价
PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):400-10.
7
Study of the inclusion of gliclazide in alpha-cyclodextrin.
J Pharm Biomed Anal. 1998 Oct;18(1-2):275-9. doi: 10.1016/s0731-7085(98)00179-4.
8
Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.研制新型格列齐特胃滞留药物输送系统:空心珠。
Drug Dev Ind Pharm. 2014 Mar;40(3):398-408. doi: 10.3109/03639045.2013.763817. Epub 2013 Feb 18.
9
Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.依折麦布与羟丙基-β-环糊精及亲水性辅料制剂的水溶解度改善及抗高胆固醇活性
AAPS PharmSciTech. 2016 Apr;17(2):272-83. doi: 10.1208/s12249-015-0344-7. Epub 2015 Jun 16.
10
Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.格列齐特β-环糊精-羟丙基甲基纤维素复合物的溶解度及降血糖活性研究
Pharmazie. 2002 Mar;57(3):191-3.

引用本文的文献

1
Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.用于治疗糖尿病的基于脂质的格列齐特纳米粒:制剂、药代动力学、药效学和亚急性毒性研究。
Int J Nanomedicine. 2020 Feb 18;15:1129-1148. doi: 10.2147/IJN.S235290. eCollection 2020.